IRIS Accounts Production v25.1.0.734 08200043 Board of Directors 1.10.23 30.9.24 30.9.24 0 0 false true false false true false Fair value model Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh082000432023-09-30082000432024-09-30082000432023-10-012024-09-30082000432022-09-30082000432022-10-012023-09-30082000432023-09-3008200043ns15:EnglandWales2023-10-012024-09-3008200043ns14:PoundSterling2023-10-012024-09-3008200043ns10:Director12023-10-012024-09-3008200043ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3008200043ns10:SmallEntities2023-10-012024-09-3008200043ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3008200043ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3008200043ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3008200043ns10:FullAccounts2023-10-012024-09-3008200043ns10:OrdinaryShareClass12023-10-012024-09-3008200043ns10:Director22023-10-012024-09-3008200043ns10:Director32023-10-012024-09-3008200043ns10:RegisteredOffice2023-10-012024-09-3008200043ns5:CurrentFinancialInstruments2024-09-3008200043ns5:CurrentFinancialInstruments2023-09-3008200043ns5:ShareCapital2024-09-3008200043ns5:ShareCapital2023-09-3008200043ns5:RetainedEarningsAccumulatedLosses2024-09-3008200043ns5:RetainedEarningsAccumulatedLosses2023-09-3008200043ns5:FurnitureFittings2023-09-3008200043ns5:ComputerEquipment2023-09-3008200043ns5:FurnitureFittings2023-10-012024-09-3008200043ns5:ComputerEquipment2023-10-012024-09-3008200043ns5:FurnitureFittings2024-09-3008200043ns5:ComputerEquipment2024-09-3008200043ns5:FurnitureFittings2023-09-3008200043ns5:ComputerEquipment2023-09-3008200043ns10:OrdinaryShareClass12024-09-3008200043ns5:RetainedEarningsAccumulatedLosses2023-09-3008200043ns5:RetainedEarningsAccumulatedLosses2023-10-012024-09-30
REGISTERED NUMBER: 08200043 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

ELIAD & GOZZARD HEALTHCARE LTD

ELIAD & GOZZARD HEALTHCARE LTD (REGISTERED NUMBER: 08200043)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


ELIAD & GOZZARD HEALTHCARE LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTORS: Dr R Eliad
Mrs S Eliad
Ms R S E Eliad





REGISTERED OFFICE: 109 Hempstead Road
Watford
Hertfordshire
WD17 3HE





REGISTERED NUMBER: 08200043 (England and Wales)





ACCOUNTANTS: Venitt and Greaves
Chartered Accountants
115 Craven Park Road
South Tottenham
London
N15 6BL

ELIAD & GOZZARD HEALTHCARE LTD (REGISTERED NUMBER: 08200043)

STATEMENT OF FINANCIAL POSITION
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £   
FIXED ASSETS
Tangible assets 4 608 858
Investment property 5 689,402 689,402
690,010 690,260

CURRENT ASSETS
Cash at bank 52,461 32,818

CREDITORS
Amounts falling due within one year 6 (38,288 ) (116,885 )
NET CURRENT ASSETS/(LIABILITIES) 14,173 (84,067 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

704,183

606,193

CAPITAL AND RESERVES
Called up share capital 7 3 2
Retained earnings 8 704,180 606,191
SHAREHOLDERS' FUNDS 704,183 606,193

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 March 2025 and were signed on its behalf by:





Dr R Eliad - Director


ELIAD & GOZZARD HEALTHCARE LTD (REGISTERED NUMBER: 08200043)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1. STATUTORY INFORMATION

Eliad & Gozzard Healthcare Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Fixtures and Fittings - 15% on reducing balance
Computer Equipment -33% on reducing balance

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

ELIAD & GOZZARD HEALTHCARE LTD (REGISTERED NUMBER: 08200043)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 October 2023
and 30 September 2024 252 6,623 6,875
DEPRECIATION
At 1 October 2023 70 5,947 6,017
Charge for year 27 223 250
At 30 September 2024 97 6,170 6,267
NET BOOK VALUE
At 30 September 2024 155 453 608
At 30 September 2023 182 676 858

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 October 2023
and 30 September 2024 689,402
NET BOOK VALUE
At 30 September 2024 689,402
At 30 September 2023 689,402

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Tax 31,409 23,953
Other creditors 6,069 92,122
Accrued expenses 810 810
38,288 116,885

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £    £   
3 Ordinary £1 3 2

ELIAD & GOZZARD HEALTHCARE LTD (REGISTERED NUMBER: 08200043)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

8. RESERVES
Retained
earnings
£   

At 1 October 2023 606,191
Profit for the year 100,989
Dividends (3,000 )
At 30 September 2024 704,180